# Using the Inactive Ingredient Database Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/using-the-inactive-ingredient-database-guidance-for-industry/0bf5000a-4dfb-4c0c-b619-fdb0e028ed1d

> FDA guidance document: Using the Inactive Ingredient Database Guidance for Industry. Issue date: July 11, 2019. Get complete insights and analysis.

---

## Details

- Title: Using the Inactive Ingredient Database Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-07-11
- Comment Close Date: 2019-10-09
- Last Changed: 2020-05-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2019-D-2397">FDA-2019-D-2397</a>

## Related Documents

- [Establishing Impurity Specifications for Antibiotics](https://www.globalkeysolutions.net/guidances/guidance-document/establishing-impurity-specifications-for-antibiotics/5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84)
- [Microbiological Quality Considerations in Non-Sterile Drug Manufacturing: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/microbiological-quality-considerations-in-non-sterile-drug-manufacturing-draft-guidance-for-industry/37a0a205-577b-4738-a343-eec1075de07d)
- [How To Obtain a Covered Product Authorization](https://www.globalkeysolutions.net/guidances/guidance-document/how-to-obtain-a-covered-product-authorization/881f0322-95f9-4bfd-b6c3-35f5df950808)